Global Skin Replacement Market Overview:
Skin replacement is a type of surgery. In this operation, medical professionals remove healthy skin from one area of the body and relocate it to cover damaged or absent skin. The grafted skin develops blood vessels and joins with the surrounding skin within a few days. Skin transplant surgery is used to treat patients who have skin damage due to burns, wounds, diseases, or infections. Increase in global life expectancy, healthcare spending, and rising number of burn patients are contributing to the growth of the market.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Historical Period | 2017-2021 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Skin Replacement Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Increase in Global Life Expectancy
- Increased Healthcare Spending
- Rising Number of Burn Patients
|
Restraints | |
Road Blocks / Challenges | - Competition from Low-Cost Substitutes
- Lack of Clinical Support
|
Gaps & Opportunities | - Expansion of Healthcare Systems
- Rising Medical Tourism Business in Emerging Countries
|
Competitive Landscape:
Global skin replacement is a consolidated market due to the presence of few players. The players are focusing on investing more in R&D. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Some of the key players profiled in the report are B. Braun Melsungen AG (Germany), Baxter (United States), Becton, Dickinson and Company (United States), Johnson & Johnson Private Limited (India), Stryker (United States), Integra LifeSciences Corporation (United States), Medtronic (Ireland), Acera Surgical, Inc. (United States), Arthrex, Inc. (United States) and Acelity L.P. Inc. (United States). Considering Market by Material Type, the sub-segment i.e. Natural Skin will boost the Skin Replacement market. Considering Market by Usability, the sub-segment i.e. Temporary skin replacement will boost the Skin Replacement market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Skin Replacement market.
Latest Market Insights:
In September 2021, B. Braun Melsungen AG acquired the minority interest of the cofounders Jean-Philippe Gentes and Bertrand Bolduc in Sterinova Inc. and now owns 100% of the company. Sterinova will continue to operate as a distinct subsidiary of B. Braun Melsungen AG.
In March 2020, Researchers from the Rensselaer Polytechnic Institute have developed a way to 3D-print living skin, complete with blood vessels. It’s an advancement that has been hailed as a step towards creating artificial grafts that appear and behave like natural skin. Medical Technology takes a look at this development and the tech helping to improve skin grafts.
What Can be Explored with the Skin Replacement Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Skin Replacement Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Skin Replacement
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Skin Replacement market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Skin Replacement market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Hospitals, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.